Global scale Antares Vision Group operates with a broad global footprint including 8 company sites, 170+ plants equipped worldwide, and 2,500+ serialization & aggregation lines, indicating substantial cross-border sales and the ability to service multinational pharma and high-demand sectors.

Pharma focus The company specializes in pharmaceuticals, medical devices, cosmetics, and food & beverage, with 100% audited by more than 45 multinational pharma customers. This signals strong credibility and a ready-made case for pharma-grade track & trace and inspection solutions.

Advanced capabilities Recent launches include AI-driven high-speed visual and leak detection, automatic visual inspection for prefilled syringes, and new compact Easy TB units, highlighting opportunities to upsell advanced inspection, leakage detection, and automation to both large and mid-size manufacturers.

Evidence of growth Major trade show activity and ongoing product introductions (Interphex, GS1 Connect, ProPak Asia) demonstrate active market expansion plans, suggesting prospects for new regional deployments and channel partnerships in Asia, North America, and Europe.

Financial health With revenue in the range of $100M-$250M and substantial funding ($144M), the company signals solid growth potential and capacity for large modernization projects, favorable for multi-year contracts on end-to-end traceability, data management, and inspection systems.